Apricus Reports National Phase Approval of ED Cream in Germany
October 07, 2013 at 07:02 AM EDT
Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq: APRI ) (www.apricusbio.com), today announced that Germany's Federal Institute for Drugs and Medical Devices (BfArM) has granted national phase approval to Vitaros^®, indicated for the treatment of patients with erectile dysfunction ("ED"). The Company has now received a total of five national phase approvals for
